StonvexLoading…
StonvexStonvexStonvexCore line items from PSFE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.70B | $1.70B | $1.60B | $1.50B |
Operating Income | $71.92M | $133.35M | $158.66M | $-1.87B |
Net Income | $-182.51M | $22.16M | $-20.25M | $-1.86B |
EPS (Diluted) | $-3.14 | $0.36 | $-0.33 | $-30.78 |
Total Assets | $4.80B | $4.81B | $5.23B | $5.96B |
Total Liabilities | $4.15B | $3.93B | $4.34B | $5.10B |
Cash & Equivalents | $250.17M | $216.68M | $202.32M | $260.22M |
Free Cash Flow OCF − CapEx | $223.58M | $237.87M | $221.17M | $232.66M |
Shares Outstanding | 51.68M | 59.89M | 61.72M | 60.79M |